Effect of melatonin on active transport of serotonin into blood platelets. 1995

A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
Gehah Psychiatric Hospital, Petah-Tiqva, Israel.

Previous research has demonstrated that the circadian rhythm of melatonin negatively correlates with that of the sensitivity of platelet serotonin uptake sites. Moreover, serotonin has been found to be a competitive inhibitor of melatonin binding to platelets. The goal of the present study was to investigate whether melatonin directly affects platelet serotonin transport. Blood samples from 12 healthy subjects were assayed for both serotonin transport into platelets. Active transport of serotonin (at a concentration of 10(-6) M) into blood platelets was measured in the presence of melatonin at physiological concentrations (10(-12) M to 2 x 10(-9) M) and high nonphysiological concentrations (2 x 10(-8) M to 2 x 10(-3) M). Melatonin inhibited serotonin uptake by blood platelets at the high concentrations only ( > 10(-5) M with IC50 value of 1.1 x 10(-3) M) and had no effect at physiological concentrations.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
July 1959, The American journal of physiology,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
July 1990, Japanese journal of pharmacology,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
August 1990, Biochemical pharmacology,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
November 1996, Japanese journal of pharmacology,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
January 1989, The Journal of pharmacology and experimental therapeutics,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
January 1985, Clinical and experimental pharmacology & physiology,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
January 1986, Harefuah,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
January 1988, Psychiatrie, Neurologie und medizinische Psychologie. Beihefte,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
October 1996, Neurochemistry international,
A Valevski, and I Modai, and Z Jerushalmy, and L Kikinzon, and A Weizman
January 1992, Journal of biochemical toxicology,
Copied contents to your clipboard!